MIA researchers feature on prestigious Highly Cited Researchers 2020 List
18 November 2020
Melanoma Institute Australia is proud to announce that MIA’s Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer, as well as MIA Faculty member Associate Professor Alex Menzies and former Faculty member Professor Rick Kefford AM, have been named on the annual Highly Cited Researchers™ 2020 list from Clarivate.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe. It identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.
Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index.
According to Clarivate, 6,167 researchers from more than 60 countries and regions have been recognized this year, with Australian research institutes continuing to punch above their weight. In a country of just 25 million, the number of Australian researchers recognized in 2020 is 305.
MIA Co-Medical Director Professor Georgina Long AO, whose video interview with Clarivate is featured online, said:
“This accolade is recognition of the ground-breaking work being carried out by the entire team at Melanoma Institute Australia as we continue our quest to develop treatments that will ultimately save the lives of all melanoma patients.”
Fellow Co-Medical Director of MIA Professor Richard Scolyer said:
“It is an honour to again be included on this list alongside several other MIA researchers and clinicians. It shows the phenomenal and ongoing impact that MIA’s work and research is having around the world.”
David Pendlebury, Senior Citation Analyst at the Institute for Scientific Information at Clarivate said:
“In the race for knowledge, it is human capital that is fundamental and this list identifies and celebrates exceptional individual researchers from Melanoma Institute Australia who are having a great impact on the research community as measured by the rate at which their work is being cited by others.”
Melanoma Institute Australia is affiliated with The University of Sydney
#HighlyCited2020
Melanoma March has officially launched
Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne.
Melanoma March is around the corner
Help us march towards a cure for melanoma research. See where your local march is and how you can get involved.
Q&A with a PhD student
Under the leadership of world-leading melanoma pathologist Prof Richard Scolyer and medical oncologist A/Prof Georgina Long, third year PhD student, Hojabr Kakavand, is at the forefront of melanoma research.
ClinTrial Refer Melanoma App
Melanoma Institute Australia has launched a new smartphone app called ClinTrial Refer Melanoma to help busy clinicians find clinical trials for their melanoma patients.
Interview on the latest melanoma treatments
MIA's Associate Professor Georgina Long and stage 4 melanoma patient, Maria, were recently interviewed by ABC Weekend Breakfast about the latest in clincial trials and melanoma treatments.
Sunbed campaigner acknowledged as one of most influential Australians
Sunbed campaigner, Jay Allen, has been acknowledged on the honour roll of Australia’s most influential people in the non-profit sector.
A world-class organisation needs a world-class website
Today we launch the website we’ve dreamed about!
Watch Your Mate's Back kicks off soon
Our new summer campaign has you and your mates' backs covered!
Saving our next generation
Researcher James Wilmott is working to fill a gap in research for young patients.
It's time to march for a cure!
Join us for our fourth annual Melanoma March and help us raise over $1 million for melanoma research as we march for a cure!
Making a difference
When Melanoma Institute Australia (MIA) patients at the Poche Centre are first diagnosed with advanced melanoma Anna Hoadley is there.
New trial offers hope to Stage IV patients
Shining new hope for patients with advanced stage melanoma.
Combination drug therapy halts disease in advanced melanoma
A world-first study in the New England Journal of Medicine heralds the effectiveness of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
Georgina Long wins award for Outstanding Cancer Research
Associate Professor Georgina Long wins award for Cancer Institute NSW
Melanoma survivors walk from Sydney to Melbourne to raise money
Melanoma survivors and long-time friends Jay Allen and Andrew Rust concluded their 900km walk from Sydney to Melbourne completing their walk at the Melbourne Cricket Ground on Saturday 26 July.
The Federal Government's 2015-16 Budget announcements benefit research
The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding.
Melanoma Essentials eBook offered for Free during EADO and GAC (PDF)
Melanoma Essentials eBook offered for Free during EADO and GAC
It's 'Game On Mole' this summer! - Copy
All Australians are urged to join the fight against melanoma this summer.
It's 'Game On Mole' this summer!
All Australians are urged to join the fight against melanoma this summer.